Dectin-1-activated dendritic cells: A potent Th9 cell inducer for tumor immunotherapy

Dendritic cell (DC)-based immunotherapy has great promise for cancer treatment. We have recently demonstrated that dectin-1-activated DCs trigger potent antitumor Th9 cells in vivo. Dectin-1-activated DC-induced antitumor responses rely on the induced Th9/IL-9. These findings offer new strategies fo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncoimmunology
Autores principales: Chen, Jintong, Zhao, Yinghua, Chu, Xiao, Lu, Yong, Wang, Siqing, Yi, Qing
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis 2016
Materias:
Author's View
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5139651/
https://ncbi.nlm.nih.gov/pubmed/27999759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1238558
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares